Other research analysts have also issued reports about the stock. JPMorgan Chase & Co. restated a "neutral" rating and issued a $350.00 price objective (down from $378.00) on shares of Molina Healthcare in a report on Tuesday, December 17th. Truist Financial decreased their price target on shares of Molina Healthcare from $400.00 to $370.00 and set a "buy" rating for the company in a research note on Monday, January 6th. Stephens reaffirmed an "equal weight" rating and set a $345.00 price objective on shares of Molina Healthcare in a research report on Thursday. UBS Group decreased their target price on Molina Healthcare from $374.00 to $325.00 and set a "neutral" rating for the company in a research report on Friday. Finally, Robert W. Baird dropped their price target on Molina Healthcare from $405.00 to $331.00 and set an "outperform" rating on the stock in a research report on Thursday, October 24th. One research analyst has rated the stock with a sell rating, seven have given a hold rating, five have assigned a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of "Hold" and an average target price of $355.67.
Get Our Latest Analysis on Molina Healthcare
Shares of NYSE:MOH opened at $283.92 on Friday. The stock's 50-day moving average is $298.55 and its 200 day moving average is $318.15. The company has a market cap of $16.24 billion, a PE ratio of 14.42, a P/E/G ratio of 0.96 and a beta of 0.54. The company has a debt-to-equity ratio of 0.53, a current ratio of 1.54 and a quick ratio of 1.55. Molina Healthcare has a 1 year low of $272.69 and a 1 year high of $423.92.
Molina Healthcare (NYSE:MOH - Get Free Report) last posted its earnings results on Wednesday, February 5th. The company reported $5.05 earnings per share (EPS) for the quarter, missing the consensus estimate of $5.74 by ($0.69). Molina Healthcare had a net margin of 2.92% and a return on equity of 27.88%. Sell-side analysts anticipate that Molina Healthcare will post 23.44 EPS for the current year.
Several institutional investors and hedge funds have recently modified their holdings of the stock. State Street Corp boosted its stake in Molina Healthcare by 0.5% in the 3rd quarter. State Street Corp now owns 2,614,311 shares of the company's stock worth $900,787,000 after purchasing an additional 13,001 shares in the last quarter. Charles Schwab Investment Management Inc. lifted its stake in shares of Molina Healthcare by 2.6% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 400,080 shares of the company's stock worth $116,443,000 after buying an additional 10,002 shares in the last quarter. Los Angeles Capital Management LLC grew its holdings in shares of Molina Healthcare by 166.1% during the fourth quarter. Los Angeles Capital Management LLC now owns 196,513 shares of the company's stock valued at $57,195,000 after buying an additional 122,674 shares during the last quarter. Swiss National Bank grew its holdings in shares of Molina Healthcare by 0.3% during the third quarter. Swiss National Bank now owns 173,900 shares of the company's stock valued at $59,919,000 after buying an additional 500 shares during the last quarter. Finally, Sumitomo Mitsui Trust Group Inc. increased its position in shares of Molina Healthcare by 2.2% during the fourth quarter. Sumitomo Mitsui Trust Group Inc. now owns 149,573 shares of the company's stock valued at $43,533,000 after acquiring an additional 3,238 shares in the last quarter. 98.50% of the stock is currently owned by institutional investors.
Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
Before you make your next trade, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis.
Our team has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and none of the big name stocks were on the list.
They believe these five stocks are the five best companies for investors to buy now...
See The Five Stocks Here
Before you consider Molina Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Molina Healthcare wasn't on the list.
While Molina Healthcare currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.